Literature DB >> 18569966

Standardization of serum creatinine measurement: theory and practice.

Gary L Myers1.   

Abstract

Chronic kidney disease (CKD) is a major global public health problem. The best indicator of kidney function is considered to be the glomerular filtration rate (GFR), the rate that blood is filtered at the glomerulus. Currently, it is recommended that GFR be estimated using the estimating equation developed from the Modification of Diet in Renal Disease (MDRD) Study. To utilize the MDRD equation effectively requires reliable serum creatinine measurement. Understanding by laboratories world-wide of the importance of reliable serum creatinine measurements in GFR estimation and of factors that may affect creatinine measurement is critical to ongoing global public health efforts to increase the identification of patients with CKD. Serum creatinine assays must be properly calibrated and traceable to a high-order reference system in order to eliminate or significantly reduce variation among laboratories. If properly standardized world-wide, serum creatinine results can be used reliably to achieve universal implementation of GFR reporting as part of the global effort to diagnose and treat CKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18569966     DOI: 10.1080/00365510802149887

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  3 in total

1.  Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES).

Authors:  Elizabeth Selvin; Stephen P Juraschek; John Eckfeldt; Andrew S Levey; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2012-11-21       Impact factor: 8.860

Review 2.  Cystatin C: a new renal marker and its potential use in small animal medicine.

Authors:  L Ghys; D Paepe; P Smets; H Lefebvre; J Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

3.  A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population.

Authors:  Robert L Schmidt; Joely A Straseski; Kalani L Raphael; Austin H Adams; Christopher M Lehman
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.